node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
DEFB1 | DEFB103A | ENSP00000297439 | ENSP00000320951 | defensin, beta 1; Has bactericidal activity (By similarity) | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | 0.788 |
DEFB1 | DEFB104A | ENSP00000297439 | ENSP00000320813 | defensin, beta 1; Has bactericidal activity (By similarity) | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | 0.414 |
DEFB1 | DEFB106A | ENSP00000297439 | ENSP00000335307 | defensin, beta 1; Has bactericidal activity (By similarity) | defensin, beta 106A; Has antibacterial activity | 0.635 |
DEFB103A | DEFB1 | ENSP00000320951 | ENSP00000297439 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 1; Has bactericidal activity (By similarity) | 0.788 |
DEFB103A | DEFB104A | ENSP00000320951 | ENSP00000320813 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | 0.473 |
DEFB103A | DEFB105A | ENSP00000320951 | ENSP00000334330 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 105A; Has antibacterial activity (Potential) | 0.473 |
DEFB103A | DEFB106A | ENSP00000320951 | ENSP00000335307 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 106A; Has antibacterial activity | 0.459 |
DEFB103A | DEFB107A | ENSP00000320951 | ENSP00000334681 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 107A; Has antibacterial activity (Potential) | 0.473 |
DEFB103A | DEFB107B | ENSP00000320951 | ENSP00000347810 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 107B; Has antibacterial activity (Potential) | 0.473 |
DEFB103A | DEFB108B | ENSP00000320951 | ENSP00000333234 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 108B; Has antibacterial activity (By similarity) | 0.473 |
DEFB104A | DEFB1 | ENSP00000320813 | ENSP00000297439 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | defensin, beta 1; Has bactericidal activity (By similarity) | 0.414 |
DEFB104A | DEFB103A | ENSP00000320813 | ENSP00000320951 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | 0.473 |
DEFB104A | DEFB105A | ENSP00000320813 | ENSP00000334330 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | defensin, beta 105A; Has antibacterial activity (Potential) | 0.728 |
DEFB104A | DEFB106A | ENSP00000320813 | ENSP00000335307 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | defensin, beta 106A; Has antibacterial activity | 0.578 |
DEFB104A | DEFB107A | ENSP00000320813 | ENSP00000334681 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | defensin, beta 107A; Has antibacterial activity (Potential) | 0.681 |
DEFB104A | DEFB108B | ENSP00000320813 | ENSP00000333234 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | defensin, beta 108B; Has antibacterial activity (By similarity) | 0.564 |
DEFB104A | FAM90A26P | ENSP00000320813 | ENSP00000395848 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | family with sequence similarity 90, member A26, pseudogene | 0.502 |
DEFB104A | LRLE1 | ENSP00000320813 | ENSP00000470948 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | Liver-related low express protein 1 | 0.506 |
DEFB105A | DEFB103A | ENSP00000334330 | ENSP00000320951 | defensin, beta 105A; Has antibacterial activity (Potential) | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | 0.473 |
DEFB105A | DEFB104A | ENSP00000334330 | ENSP00000320813 | defensin, beta 105A; Has antibacterial activity (Potential) | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | 0.728 |